CN107663553A - 用于将及时现场护理快速诊断测试结果与基于实验室的方法相连的方法 - Google Patents
用于将及时现场护理快速诊断测试结果与基于实验室的方法相连的方法 Download PDFInfo
- Publication number
- CN107663553A CN107663553A CN201710902140.1A CN201710902140A CN107663553A CN 107663553 A CN107663553 A CN 107663553A CN 201710902140 A CN201710902140 A CN 201710902140A CN 107663553 A CN107663553 A CN 107663553A
- Authority
- CN
- China
- Prior art keywords
- sample
- test
- processed
- laboratory
- quick
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000012360 testing method Methods 0.000 title claims abstract description 124
- 238000000034 method Methods 0.000 title claims abstract description 41
- 238000003745 diagnosis Methods 0.000 title description 6
- 238000012545 processing Methods 0.000 claims abstract description 41
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 26
- 108020004707 nucleic acids Proteins 0.000 claims abstract description 11
- 102000039446 nucleic acids Human genes 0.000 claims abstract description 11
- 150000007523 nucleic acids Chemical class 0.000 claims abstract description 11
- 238000003018 immunoassay Methods 0.000 claims abstract description 10
- 238000009533 lab test Methods 0.000 claims abstract description 9
- 150000003839 salts Chemical class 0.000 claims abstract description 8
- 239000000872 buffer Substances 0.000 claims abstract description 7
- 239000003599 detergent Substances 0.000 claims abstract description 7
- 244000005700 microbiome Species 0.000 claims abstract description 7
- 238000012546 transfer Methods 0.000 claims description 36
- 239000003085 diluting agent Substances 0.000 claims description 33
- 239000003795 chemical substances by application Substances 0.000 claims description 14
- 230000008569 process Effects 0.000 claims description 9
- 230000006641 stabilisation Effects 0.000 claims description 5
- 238000011105 stabilization Methods 0.000 claims description 5
- 238000000354 decomposition reaction Methods 0.000 claims description 2
- 239000003381 stabilizer Substances 0.000 abstract 2
- 239000000523 sample Substances 0.000 description 116
- 238000003757 reverse transcription PCR Methods 0.000 description 22
- 108020000999 Viral RNA Proteins 0.000 description 15
- 208000037797 influenza A Diseases 0.000 description 15
- 238000002123 RNA extraction Methods 0.000 description 13
- 239000000499 gel Substances 0.000 description 11
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 10
- 206010022000 influenza Diseases 0.000 description 8
- 238000002360 preparation method Methods 0.000 description 8
- 239000012895 dilution Substances 0.000 description 7
- 238000010790 dilution Methods 0.000 description 7
- 239000002609 medium Substances 0.000 description 7
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- 239000013614 RNA sample Substances 0.000 description 5
- 230000003196 chaotropic effect Effects 0.000 description 5
- 208000037798 influenza B Diseases 0.000 description 5
- 239000011159 matrix material Substances 0.000 description 5
- 238000005259 measurement Methods 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 239000012898 sample dilution Substances 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 238000012790 confirmation Methods 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 230000003612 virological effect Effects 0.000 description 4
- 241000712431 Influenza A virus Species 0.000 description 3
- 108010061100 Nucleoproteins Proteins 0.000 description 3
- 239000007983 Tris buffer Substances 0.000 description 3
- 239000002738 chelating agent Substances 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 229940125532 enzyme inhibitor Drugs 0.000 description 3
- 239000002532 enzyme inhibitor Substances 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 102000011931 Nucleoproteins Human genes 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 239000012472 biological sample Substances 0.000 description 2
- 238000005336 cracking Methods 0.000 description 2
- 238000002405 diagnostic procedure Methods 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 102000044158 nucleic acid binding protein Human genes 0.000 description 2
- 108700020942 nucleic acid binding protein Proteins 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 241000712461 unidentified influenza virus Species 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 1
- 241000606153 Chlamydia trachomatis Species 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 206010022004 Influenza like illness Diseases 0.000 description 1
- 102100034343 Integrase Human genes 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 238000010222 PCR analysis Methods 0.000 description 1
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 102000023732 binding proteins Human genes 0.000 description 1
- 108091008324 binding proteins Proteins 0.000 description 1
- 101150118925 bioM gene Proteins 0.000 description 1
- 239000013060 biological fluid Substances 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229940038705 chlamydia trachomatis Drugs 0.000 description 1
- 239000011162 core material Substances 0.000 description 1
- 239000012228 culture supernatant Substances 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- ZJYYHGLJYGJLLN-UHFFFAOYSA-N guanidinium thiocyanate Chemical compound SC#N.NC(N)=N ZJYYHGLJYGJLLN-UHFFFAOYSA-N 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 239000006101 laboratory sample Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000001989 nasopharynx Anatomy 0.000 description 1
- 239000013610 patient sample Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000011514 reflex Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 239000006163 transport media Substances 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Virology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Tropical Medicine & Parasitology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Sampling And Sample Adjustment (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US36607610P | 2010-07-20 | 2010-07-20 | |
| US61/366,076 | 2010-07-20 | ||
| CN201180039453XA CN103069002A (zh) | 2010-07-20 | 2011-07-20 | 用于将及时现场护理快速诊断测试结果与基于实验室的方法相连的方法 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201180039453XA Division CN103069002A (zh) | 2010-07-20 | 2011-07-20 | 用于将及时现场护理快速诊断测试结果与基于实验室的方法相连的方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN107663553A true CN107663553A (zh) | 2018-02-06 |
Family
ID=45497436
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710902140.1A Pending CN107663553A (zh) | 2010-07-20 | 2011-07-20 | 用于将及时现场护理快速诊断测试结果与基于实验室的方法相连的方法 |
| CN201180039453XA Pending CN103069002A (zh) | 2010-07-20 | 2011-07-20 | 用于将及时现场护理快速诊断测试结果与基于实验室的方法相连的方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201180039453XA Pending CN103069002A (zh) | 2010-07-20 | 2011-07-20 | 用于将及时现场护理快速诊断测试结果与基于实验室的方法相连的方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US9945855B2 (https=) |
| EP (2) | EP3257948B1 (https=) |
| JP (1) | JP5911861B2 (https=) |
| CN (2) | CN107663553A (https=) |
| AU (1) | AU2011282214B2 (https=) |
| CA (1) | CA2805486C (https=) |
| ES (1) | ES2761654T3 (https=) |
| WO (1) | WO2012012527A2 (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10235727B2 (en) * | 2011-09-13 | 2019-03-19 | Monk Akarshala Design Private Limited | Learning facility management in a modular learning system |
| IN2014DN09302A (https=) | 2012-04-13 | 2015-07-10 | Becton Dickinson Co | |
| WO2015019195A2 (en) * | 2013-08-07 | 2015-02-12 | Xagenic Inc. | Systems, devices, and methods for deploying onboard reagents in a diagnostic device |
| GB201703383D0 (en) | 2017-03-02 | 2017-04-19 | Gargle Tech Ltd | Testing for particulates |
| WO2019118989A1 (en) | 2017-12-15 | 2019-06-20 | Evanostics Llc | Optical reader for analyte testing |
| EP4205851A3 (en) | 2018-09-05 | 2023-10-04 | Hero Scientific Ltd | Testing for particulates |
| US11864868B2 (en) * | 2018-12-12 | 2024-01-09 | Morgan State University | Modular, portable and rapidly deployable system for health assessment |
| WO2020132146A1 (en) | 2018-12-18 | 2020-06-25 | Evanostics Llc | Optical analyte detection |
| US12449336B2 (en) | 2020-03-11 | 2025-10-21 | Hero Scientific Ltd. | Testing devices |
| EP4165385B1 (en) | 2021-01-06 | 2024-04-17 | Hero Scientific Ltd | Filtration sampling devices |
Family Cites Families (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE791340A (fr) * | 1972-01-06 | 1973-03-01 | Becton Dickinson Co | Nouveaux procede et appareil de prelevement de culture et d'identification de micro-organismes des humeurs |
| US4666850A (en) | 1983-10-28 | 1987-05-19 | Becton, Dickinson And Company | Microbial pathogen detecting system and process |
| US4693972A (en) * | 1984-01-16 | 1987-09-15 | Becton, Dickinson And Company | Composition and method for rapid detection of microorganisms in clinical samples |
| US4618576A (en) * | 1984-02-27 | 1986-10-21 | Becton Dickinson And Company | Diagnostic test for Streptococcus A |
| US5091316A (en) * | 1988-06-09 | 1992-02-25 | Becton, Dickinson And Company | Biological sample collection and transport device |
| US5084005A (en) * | 1988-07-13 | 1992-01-28 | Becton, Dickinson And Company | Swab for collection of biological samples |
| US5700636A (en) * | 1990-10-19 | 1997-12-23 | Becton Dickinson And Company | Methods for selectively detecting microorganisms associated with vaginal infections in complex biological samples |
| US5747265A (en) * | 1992-10-30 | 1998-05-05 | T Cell Diagnostics, Inc. | Method for measuring the amount of a cell-associated molecule |
| US6514461B1 (en) * | 1997-02-14 | 2003-02-04 | Escreen, Inc. | System for automatically testing a fluid specimen |
| US6267722B1 (en) * | 1998-02-03 | 2001-07-31 | Adeza Biomedical Corporation | Point of care diagnostic systems |
| US6394952B1 (en) * | 1998-02-03 | 2002-05-28 | Adeza Biomedical Corporation | Point of care diagnostic systems |
| US6602718B1 (en) * | 2000-11-08 | 2003-08-05 | Becton, Dickinson And Company | Method and device for collecting and stabilizing a biological sample |
| ATE384954T1 (de) * | 2000-11-08 | 2008-02-15 | Becton Dickinson Co | Verfahren und vorrichtung zum sammeln und zum stabilisieren einer biologischen probe |
| US20040176705A1 (en) * | 2003-03-04 | 2004-09-09 | Stevens Timothy A. | Cartridge having an integrated collection element for point of care system |
| US7662562B2 (en) * | 2004-08-10 | 2010-02-16 | Becton, Dickinson And Company | Method for rapid identification of microorganisms |
| JP2006084351A (ja) * | 2004-09-16 | 2006-03-30 | Denka Seiken Co Ltd | 検体浮遊液組成物、キット及び検査方法 |
| US20060246423A1 (en) | 2005-02-10 | 2006-11-02 | Adelson Martin E | Method and kit for the collection and maintenance of the detectability of a plurality of microbiological species in a single gynecological sample |
| US20060286557A1 (en) * | 2005-06-15 | 2006-12-21 | Basehore Lee S | Combined lysis and PCR buffer |
| GB0601302D0 (en) * | 2006-01-23 | 2006-03-01 | Semikhodskii Andrei | Diagnostic methods and apparatus |
| AU2007217765A1 (en) | 2006-02-21 | 2007-08-30 | Nanogen, Inc. | Methods and compositions for analyte detection |
| US20090098527A1 (en) * | 2006-09-12 | 2009-04-16 | Fischer Gerald W | Biological organism identification product and methods |
| US8080645B2 (en) * | 2007-10-01 | 2011-12-20 | Longhorn Vaccines & Diagnostics Llc | Biological specimen collection/transport compositions and methods |
| US8097419B2 (en) * | 2006-09-12 | 2012-01-17 | Longhorn Vaccines & Diagnostics Llc | Compositions and method for rapid, real-time detection of influenza A virus (H1N1) swine 2009 |
| US7989185B2 (en) * | 2006-11-29 | 2011-08-02 | The Board Of Trustees Of The Leland Stanford Junior University | Rapid, informative diagnostic assay for influenza viruses including H5N1 |
| JP5431644B2 (ja) | 2006-12-28 | 2014-03-05 | シスメックス株式会社 | 呼吸器感染症の検査方法 |
| EP2118634A2 (en) * | 2007-02-05 | 2009-11-18 | Andrew Homer Nathaniel | Drug detection kit and method |
| US7748283B2 (en) * | 2007-02-16 | 2010-07-06 | Whatman, Inc. | Controlled transfer biological sample collection devices and methods of using such devices |
| TW200844441A (en) * | 2007-05-11 | 2008-11-16 | Animal Health Res Inst Council Of Agriculture | Method of testing foot–and- mouth disease (FMD) by using immunochromatographic |
| CA2861667C (en) * | 2007-10-01 | 2017-06-13 | Longhorn Vaccines And Diagnostics, Llc | Biological specimen collection and transport system and methods of use |
| US20110065108A1 (en) * | 2008-02-01 | 2011-03-17 | Siemens Healthcare Diagnostics Inc. | Urine Transport Medium |
| US8802370B2 (en) | 2008-05-23 | 2014-08-12 | Strand Diagnostics, Llc | Method and apparatus to minimize diagnostic and other errors due to transposition of biological specimens among subjects |
| JPWO2010064628A1 (ja) * | 2008-12-05 | 2012-05-10 | オリンパス株式会社 | 核酸含有試料の調製方法、試料調製用溶液、及び核酸の解析方法 |
| USD655424S1 (en) * | 2009-11-18 | 2012-03-06 | Becton, Dickinson And Company | Cassette for a medical device |
| EP2536855A4 (en) * | 2010-02-19 | 2013-07-31 | Argylla Technologies | ISOLATION OF BIOMOLECULES FROM BIOLOGICAL SAMPLES |
| AP2014007466A0 (en) * | 2011-08-04 | 2014-02-28 | Univ California | Salvia collection, processing, stabilization, and storage method |
| US8603769B2 (en) * | 2011-10-07 | 2013-12-10 | Becton, Dickinson And Company | Method for direct and rapid identification of microorganisms and antimicrobial susceptibility testing from positive blood cultures |
-
2011
- 2011-07-20 CN CN201710902140.1A patent/CN107663553A/zh active Pending
- 2011-07-20 EP EP17165677.0A patent/EP3257948B1/en active Active
- 2011-07-20 EP EP11810337.3A patent/EP2596121A4/en not_active Ceased
- 2011-07-20 US US13/810,948 patent/US9945855B2/en active Active
- 2011-07-20 WO PCT/US2011/044674 patent/WO2012012527A2/en not_active Ceased
- 2011-07-20 CN CN201180039453XA patent/CN103069002A/zh active Pending
- 2011-07-20 ES ES17165677T patent/ES2761654T3/es active Active
- 2011-07-20 AU AU2011282214A patent/AU2011282214B2/en active Active
- 2011-07-20 JP JP2013520836A patent/JP5911861B2/ja active Active
- 2011-07-20 CA CA2805486A patent/CA2805486C/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CN103069002A (zh) | 2013-04-24 |
| CA2805486C (en) | 2018-03-06 |
| JP2013533487A (ja) | 2013-08-22 |
| EP3257948B1 (en) | 2019-10-02 |
| US9945855B2 (en) | 2018-04-17 |
| EP2596121A2 (en) | 2013-05-29 |
| WO2012012527A8 (en) | 2013-03-14 |
| ES2761654T3 (es) | 2020-05-20 |
| EP3257948A1 (en) | 2017-12-20 |
| CA2805486A1 (en) | 2012-01-26 |
| WO2012012527A3 (en) | 2012-07-05 |
| EP2596121A4 (en) | 2013-12-18 |
| AU2011282214A1 (en) | 2013-02-07 |
| WO2012012527A2 (en) | 2012-01-26 |
| AU2011282214B2 (en) | 2015-07-23 |
| US20130216998A1 (en) | 2013-08-22 |
| JP5911861B2 (ja) | 2016-04-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN107663553A (zh) | 用于将及时现场护理快速诊断测试结果与基于实验室的方法相连的方法 | |
| Sharma et al. | COVID-19 diagnosis: current and future techniques | |
| AU2021287968A1 (en) | CRISPR-based SARS-CoV-2 detection | |
| CN103276099B (zh) | 用于荧光定量pcr检测幽门螺杆菌的引物和试剂盒 | |
| WO2023044117A1 (en) | Drain fluid for diagnostics | |
| EP4229221B1 (en) | Method for parallel nucleic acid analysis | |
| CN111344419A (zh) | 用于结核病诊断的试剂盒和用于通过使用所述试剂盒来诊断结核病的方法 | |
| EP3302707A1 (en) | Urine metabolite profiles identify kidney allograft status | |
| CN106811512A (zh) | 一种快速检测人y染色体azf区微缺失的方法、试剂盒及其制备 | |
| Huang et al. | A high-throughput strategy for COVID-19 testing based on next-generation sequencing | |
| CN118006766B (zh) | Pola2在诊断代谢综合征中的应用 | |
| CN101705300B (zh) | 鉴定马尔尼菲青霉菌的专用探针与基因芯片 | |
| JP2023517053A (ja) | Ｃｄｉ増強ｃｏｖｉｄ－１９検査 | |
| WO2021160849A1 (en) | Kits and methods for extracting nucleic acids from complex samples kits and methods for extracting nucleic acids from complex samples | |
| CN114574565A (zh) | 通过宏基因组测序确定环境样本中存在预定物种的方法 | |
| JP2005531751A (ja) | 固体担体に投与された核酸の保存および検出 | |
| WO2017027627A1 (en) | Biological sample preparation for testing | |
| JP5532635B2 (ja) | 核酸含有リポソームを用いた遺伝子解析方法及び遺伝子解析キット | |
| WO2021209994A1 (en) | Efficient testing of carrier frequency in a population | |
| Joglekar et al. | Quantitative estimation of multiple miRNAs and mRNAs from a single cell | |
| CN117701741B (zh) | 一种用于鉴别结核分枝杆菌复合群和非结核分枝杆菌的引物组及其应用 | |
| WO2019178465A1 (en) | Methods for joint low-pass and targeted sequencing | |
| EP1193313A1 (en) | Method for determining hiv-1 subtype | |
| WO2025260192A1 (en) | Methods and systems for detecting and identifying a virus using a lateral flow assay | |
| HK40066397A (zh) | 通过宏基因组测序确定环境样本中存在预定物种的方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |